Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia

doi:10.3748/wjg.v20.i20.6244

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 20

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9282)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

545

WORD

232

HTML

6139

Figures (1-3)

700

Tables (1-3)

233

Sum=7849

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

781

Download

652

Sum=1433

May 28, 2014 (publication date) through Mar 2, 2025

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 28, 2014; 20(20): 6244-6251
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6244

Table 3 The most updated hepatocellular carcinoma risk score for chronic hepatitis B patients upgraded from the REVEAL nomogram

Baseline hepatocellular carcinoma predictor	Risk score
Age (yr)
30-34	0
35-39	1
40-44	2
45-49	3
50-54	4
55-59	5
60-65	6
Sex
Female	0
Male	2
Levels of ALT (IU/L)
< 15	0
15-44	1
≥ 45	2
Family history of hepatocellular carcinoma
No	0
Yes	2
HBeAg/HBV DNA/HBsAg/genotype
Negative/< 10⁴/< 100/any type	0
Negative/< 10⁴/100-999/any type	2
Negative/< 10⁴/≥ 1000/any type	2
Negative/10⁴-10⁶/< 100/any type	3
Negative/10⁴-10⁶/100-999/any type	3
Negative/10⁴-10⁶/≥ 1000/any type	4
Negative/≥ 10⁶/any level/B or B + C	5
Negative/≥ 10⁶/any level/C	7
Positive/any level/any level/B or B + C	6
Positive/any level/any level/C	7

ALT: Alanine transaminase; HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen.

Citation: Yang HI, Lee MH, Liu J, Chen CJ. Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia. World J Gastroenterol 2014; 20(20): 6244-6251
URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6244.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6244